newsfilter
← Latest News
ClinicalTrials.gov·

Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation - NCT05205863

Peak thrombin generation at 30 minutes after end of the Cofact infusion, Changes in ETP, Concentration in clotting factors, (and 3 more...)